➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
McKinsey
Baxter
Dow
Moodys

Last Updated: September 16, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AVANAFIL

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Avanafil

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00769041 ↗ A Thorough EKG Safety Study of TA-1790 (Avanafil) Completed Covance Phase 1 2008-10-01 This study is to assess whether treatment with a therapeutic (100 mg) or supratherapeutic (800 mg) dose of avanafil has the potential to cause QT/QTc prolongation in healthy volunteers.
NCT00769041 ↗ A Thorough EKG Safety Study of TA-1790 (Avanafil) Completed VIVUS, Inc. Phase 1 2008-10-01 This study is to assess whether treatment with a therapeutic (100 mg) or supratherapeutic (800 mg) dose of avanafil has the potential to cause QT/QTc prolongation in healthy volunteers.
NCT00770042 ↗ To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil Completed VIVUS, Inc. Phase 1 2008-10-01 This study is being conducted to examine the effect of three CYP3A4 inhibitors (ketoconazole, erythromycin and ritonavir) on the single dose pharmacokinetics of avanafil. Ketoconazole and ritonavir are potent inhibitors of CYP3A4 and erythromycin is a moderate CYP3A4 inhibitor. Any interaction that is observed would be predictive of other inhibitors of CYP3A4.
NCT00790751 ↗ Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED Completed VIVUS, Inc. Phase 3 2008-11-01 This study is being conducted to compare the safety and efficacy of 3 doses of avanafil to placebo in men with mild to severe erectile dysfunction.
NCT00809471 ↗ Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D) Completed VIVUS, Inc. Phase 3 2008-12-01 This study is being conducted to compare the safety and efficacy of 2 doses of avanafil to placebo in diabetic men with mild to severe erectile dysfunction.
NCT00853606 ↗ Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction Completed VIVUS, Inc. Phase 3 2009-03-01 This open-label study is being conducted to evaluate the long-term safety, tolerability, and efficacy of avanafil in men with mild to severe erectile dysfunction. Approximately 400 subjects will be enrolled and treated with avanafil for up to 52 weeks.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Avanafil

Condition Name

Condition Name for Avanafil
Intervention Trials
Erectile Dysfunction 19
Semen Exposure 1
Renal 1
Overactive Bladder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Avanafil
Intervention Trials
Erectile Dysfunction 20
Urinary Incontinence 1
Urinary Bladder, Overactive 1
Enuresis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Avanafil

Trials by Country

Trials by Country for Avanafil
Location Trials
United States 88
Korea, Republic of 3
Russian Federation 1
Egypt 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Avanafil
Location Trials
Arizona 8
Florida 6
Texas 5
Pennsylvania 5
Ohio 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Avanafil

Clinical Trial Phase

Clinical Trial Phase for Avanafil
Clinical Trial Phase Trials
Phase 4 4
Phase 3 7
Phase 2 1
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Avanafil
Clinical Trial Phase Trials
Completed 23
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Avanafil

Sponsor Name

Sponsor Name for Avanafil
Sponsor Trials
VIVUS, Inc. 18
JW Pharmaceutical 2
Astellas Pharma US, Inc. 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Avanafil
Sponsor Trials
Industry 23
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Medtronic
Mallinckrodt
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.